SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Silver Spike Investment Corp. SSIC NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Silver Spike Investment Corp. (SSIC) 是一家制药 - 专科与仿制药公司，属于医疗保健行业, 目前交易价格为 $10.74. 其SharesGrow评分为 55/100, 表明高于平均的投资特征， 7项中通过2项.

财务数据: 营收为 $54.3B, +61689.3%/yr 平均增长. 净利润率为 0% (较薄). 毛利率为 0% (-100 pp 趋势).

资产负债表: 总债务为 $25.0B 对比 $303.4B 股东权益 (D/E比率 0.08, 保守). 流动比率为 0.24 (流动性紧张). 资产负债率为 7.3%. 总资产: $342.0B.

分析师展望: 2 / 3 位分析师评级 SSIC 为买入 (67%) — 适度共识.

SharesGrow 7项标准细分: Value 100/100 (Pass), Growth 100/100 (Pass), Past 50/100 (Partial), Health 33/100 (Fail), Moat 20/100 (Fail), Future 55/100 (Partial), Income 30/100 (Fail).

SSIC SharesGrow 评分概览

55/100

SharesGrow Score

Above average fundamentals

View full scorecard →

价值 100/100

估值 — P/E, PEG, Forward PEG

成长 100/100

财务数据 — 平均增长

过去 50/100

强劲 — 趋势

健康 33/100

资产负债表 — D/E比率, 流动比率为

护城河 20/100

毛利率为 + market cap

未來 55/100

分析师展望 — 为买入

收入 30/100

净利润率为

Scores derived from financial statements, analyst ratings, and balance sheet data.

评分明细 — SSIC

SSIC 市盈率(P/E)为 N/A (S&P 500平均约25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上涨空间 (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SSIC: +61689.3%/yr 营收为, +114.9%/yr 净利润为平均增长. > 5%/yr — 强劲. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SSIC: 2 / 4 年盈利. 较弱. Score = 2 / 4 × 100. ≥ 80 = Pass.

View details →

资产负债表 SSIC: D/E比率 0.08 (保守), 流动比率为 0.24 (流动性紧张). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SSIC: 毛利率为 0% (-100 pp 趋势), N/A market cap. Moat (0-100): margin (35%) + 趋势 (15%) + market cap (30%) + 营收为 (20%). Score 20/100. ≥ 70 = Pass.

View details →

分析师展望: 2 / 3 位分析师评级 SSIC 为买入 (67%). Score: 60% buy consensus + 40% 上涨空间. ≥ 60 = Pass.

View details →

SSIC: 净利润率为 0%. 较薄 (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

股票图表与统计

市场数据

52周区间7.29-12.97

成交量5.82K

30日平均成交量8.78K

市值$66.72M

Beta（1年）0.28

股息率$1.0000

股份统计

EPS（TTM）1.45

流通股数$22.82M

IPO日期2022-02-04

首席执行官Scott Charles Gordon

财务亮点与比率

营收（TTM）$54.3B

现金总额$2.93B

总负债$25B

净负债$22.07B

总资产$342B

市盈率（P/E）7.4

市销率（P/S）0

分析师预测

评级共识Buy

覆盖分析师数3

买入 67% 持有 33% 卖出 0%

公司信息

国家US

交易所NASDAQ Global Market

货币USD

ISINUS8281741020

股价走势

SSIC

Silver Spike Investment Corp. ↗ · NASDAQ Global Market

Healthcare • Drug Manufacturers - Specialty & Generic

7.29 52周区间 12.97

其他人也在看

RAMM Pharma Corp.

Pure Harvest Corporate Group, Inc.

City View Green Holdings Inc.

Entourage Health Corp.

Speakeasy Cannabis Club Ltd.

RavenQuest BioMed Inc.

Craftport Cannabis Corp.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言